Medical Director - Clinical Development - Oncology

GRAIL is a healthcare company whose mission is to detect cancer early, when it can be cured. GRAIL is focused on alleviating the global burden of cancer by developing pioneering technology to detect and identify multiple deadly cancer types early. The company is using the power of next-generation sequencing, population-scale clinical studies, and state-of-the-art computer science and data science to enhance the scientific understanding of cancer biology, and to develop its multi-cancer early detection blood test. GRAIL is headquartered in Menlo Park, CA with locations in Washington, D.C., North Carolina, and the United Kingdom. GRAIL, LLC is a wholly-owned subsidiary of Illumina, Inc. (NASDAQ:ILMN). For more information, please visit www.grail.com.

Medical Director
The Medical Director in Clinical Development is responsible for providing clinical expertise to support the design, conduct, and analysis of clinical studies in support of GRAIL’s product pipeline as well as commercial launch and post-marketing commitments.  This role will interact with cross-functional teams, including colleagues from clinical operations, biostatistics, clinical data management, and other functions.

You Will:

• Collaborate with medical directors, clinical data managers, biostatisticians, data scientists, software engineers and other key functional stakeholders on the design, conduct and analysis of clinical studies
• Collaborate with colleagues from biostatistics to develop and statistical analysis pans and serve as a co-author on clinical study reports and other study deliverables
• Act as medical monitor for designated clinical studies
• Provide scientific and medical support for publications and presentations to ensure scientific and medical accuracy and cross-functional alignment
• Support efforts to advance the clinical development and scientific plans (review and interpretation of study data; engagement of key opinion leaders; providing strategic and scientific input to study-level and program-level teams)
• Develop formal networks with external investigators and thought leaders to support clinical study programs
• Ensure compliance with evolving company industry regulations and policies, and standards

Your Background Will Include:

• MD required, board certified/board eligible in oncology preferred
• Minimum of 3 years of experience in a diagnostics or pharmaceutical Clinical Development setting 
• Experience in designing and conducting clinical studies, particularly registrational and/or clinical utility studies for reimbursement
• Experience in oncology, genomics, diagnostics, cell-free DNA-based applications, or similar applied medical fields is strongly preferred
• Knowledge of regulatory requirements (e.g. ICH, GCP, HIPAA) and a commitment to compliance
• Excellent verbal and written communication and presentation skills
• Strong leadership and collaboration skills

GRAIL is an Equal Employment Office and Affirmative Action Employer and does not discriminate on the basis of race, color, religion, sex, sexual orientation, gender identity, national origin, protected veteran status, disability or any other legally protected status. We will reasonably accommodate all individuals with disabilities so that they can participate in the job application or interview process, to perform essential job functions, and to receive other benefits and privileges of employment. Please contact us to request accommodation.

Following extensive monitoring, research, consideration of business implications, and advice from internal and external experts, GRAIL has made the decision to require all U.S. employees receive the COVID-19 vaccines as a condition of employment. “Full vaccination” is defined as two weeks after both doses of a two-dose vaccine or two weeks since a single-dose vaccine has been administered. Anyone unable to be vaccinated, either because of a sincerely held religious belief or a medical condition or disability that prevents them from being vaccinated, can request a reasonable accommodation.